Literature DB >> 7536124

The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer.

A V D'Amico1, R Whittington, M Schnall, S B Malkowicz, J E Tomaszewski, D Schultz, A Wein.   

Abstract

BACKGROUND: The introduction of the endorectal coil magnetic resonance imaging (MRI) technique has improved the accuracy of preoperative staging for prostate cancer. This study quantifies the improvement in the ability to identify clinically unsuspected extraprostatic disease with the use of the endorectal coil MRI.
METHODS: A retrospective review of the pathologic findings of 347 patients with prostate cancer treated with a radical retropubic prostatectomy was performed. The preoperative clinical indicators including prostate specific antigen (PSA), clinical stage, Gleason score, and endorectal coil MRI data were employed in a multivariate analysis to identify patients who were at high risk for seminal vesicle invasion (SVI) or extracapsular extension (ECE). The sensitivity, specificity, and positive and negative predictive values for predicting SVI and ECE were calculated using the significant clinical indicators found on the multivariate analysis.
RESULTS: The clinical factors identified on multivariate analysis as significant predictors of SVI include the endorectal coil MRI data (P < 0.0001), PSA (P = 0.0096), and the Gleason score (P = 0.012). Endorectal coil MRI data (P < 0.0001), PSA (P = .0001), and Gleason score (P < .0001) were significant predictors of ECE. In the patient subgroup with PSA (> 10-20 ng/ml) and Gleason score of 5 to 7, the addition of the endorectal coil MRI data enabled an additional 71 and 27% of patients with SVI and ECE, respectively, to be correctly identified. These patients would have been missed based on the prediction obtained from the PSA and Gleason score alone.
CONCLUSIONS: The use of the endorectal coil magnetic resonance imaging data, in addition to prostate specific antigen and Gleason score, provides a more accurate prediction of the pathologic outcome of seminal vesicle invasion and extracapsular extension than the PSA and Gleason score alone for the patient subgroup with a PSA of greater than 10 to 20 ng/ml and Gleason score of 5 to 7.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536124     DOI: 10.1002/1097-0142(19950501)75:9<2368::aid-cncr2820750929>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage.

Authors:  Stephen A Brassell; William R Krueger; Jong-Ho Choi; John A Taylor
Journal:  World J Urol       Date:  2004-09-09       Impact factor: 4.226

2.  Accuracy of preoperative endo-rectal coil magnetic resonance imaging in detecting clinical under-staging of localized prostate cancer.

Authors:  Antonio B Porcaro; Alessandro Borsato; Mario Romano; Teodoro Sava; Claudio Ghimenton; Filippo Migliorini; Carmelo Monaco; Emanuele Rubilotta; Stefano Zecchini Antoniolli; Vincenzo Lacola; Stefania Montemezzi
Journal:  World J Urol       Date:  2012-07-07       Impact factor: 4.226

Review 3.  Primary staging of prostate cancer.

Authors:  G J Jager; J O Barentz; E T Ruijter; J J de la Rosette; G O Oosterhof
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.

Authors:  Thomas J Pugh; Steven J Frank; Mary Achim; Deborah A Kuban; Andrew K Lee; Karen E Hoffman; Sean E McGuire; David A Swanson; Rajat Kudchadker; John W Davis
Journal:  Brachytherapy       Date:  2012-06-05       Impact factor: 2.362

5.  Endorectal coil MRI and MR-spectroscopic imaging in patients with elevated serum prostate specific antigen with negative trus transrectal ultrasound guided biopsy.

Authors:  Farooq Ahmad Ganie; Mohammad Saleem Wani; Feroz Shaheen; Mohd Lateef Wani; Shabir Ahmad Ganie; Mohd Farooq Mir; Shadab Nabi Wani
Journal:  Urol Ann       Date:  2013-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.